PHGE
BiomX Inc.
$0.6815
-9.97%
$7.7M
No data for this timeframe.
Vol
Market Cap$7.7M
Cap SizeNano Cap
Insider Activity0B / 5S
Insider Net $-$14.8M
Reddit Sentiment57° Neutral
SEC Reports5
Press Releases2
Exchange NYSE·Sector Biological Products, (No Diagnostic Substances)·Inc. DE·CIK 0001739174·Prev Close $0.7570
Recent Activity
Jun 2, 2026
other
Another Prominent Defense Technology Leader Joins BiomX: Prof. Gabby Sarusi, Former VP and Chief Scientist at Elbit
Defense-industry veteran brings experience developing imaging, sensing, and intelligence systems for
May 28, 2026
SEC
BiomX Inc. appointed Roy Rousso as Chief Business Officer (and, per the consulting agreement, COO/CBO) effective July 1,
8-K — Impact 2/10
Apr 30, 2026
SEC
BiomX filed Amendment No. 1 to its 2025 10-K solely to add Part III items (directors, executive compensation, security o
10-K/A — Impact 3/10
Apr 16, 2026
SEC
BiomX subsidiary Zorronet secured a framework supply agreement with Israel Railways to deploy AI-powered animal detectio
8-K — Impact 5/10
Apr 13, 2026
Press
BiomX (PHGE) announced a definitive agreement to acquire a controlling interest in DFSL, an Israeli defense engineering
Impact 7/10
Apr 10, 2026
Press
BiomX (PHGE) has completed the acquisition of Zorronet, an AI-powered command-and-control software company, from Water.i
Impact 7/10
Mar 17, 2026
Insider
Yeganeh Reuven sold 530,000 shares
Director @ $2.00 ($1.1M)
Mar 17, 2026
Insider
Yeganeh Reuven sold 530,000 shares
Director @ $5.00 ($2.6M)
Price Targets
Historical data — last covering-analyst action Mar 2026. No current recommendation available.
$304.00 (Mar 2026)
Current $0.5902
Low $304.00
Median $304.00
High $304.00
1 analysts
$304.00
$304.00
Analyst Ratings
2Strong Buy
4Buy
2Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Mar 9, 2026 | HC Wainwright & Co. | DOWNGRADE | Buy → Neutral |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current FY | $-5.85 | $-5.85 — $-5.85 | 74% YoY | 1 |
| Next FY | $-6.01 ▲ +53.7% | $-6.01 — $-6.01 | -3% YoY | 1 |
Latest Reports
NEUTRAL
8-K
2/10
BiomX Inc. appointed Roy Rousso as Chief Business Officer (and, per the consulting agreement, COO/CBO) effective July 1,
May 28, 2026
NEUTRAL
10-K/A
3/10
BiomX filed Amendment No. 1 to its 2025 10-K solely to add Part III items (directors, executive compensation, security o
Apr 30, 2026
BULLISH
Press
7/10
BiomX (PHGE) announced a definitive agreement to acquire a controlling interest in DFSL, an Israeli defense engineering
Apr 13, 2026
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Mar 17, 2026 | Yeganeh Reuven | C | $1.1M |
| Mar 17, 2026 | Yeganeh Reuven | SELL | $2.6M |
| Mar 17, 2026 | Yeganeh Reuven | C | $0.00 |
| Mar 16, 2026 | Yeganeh Reuven | C | $900.0K |
| Mar 16, 2026 | Yeganeh Reuven | SELL | $2.3M |
Reddit Sentiment
57°
Neutral
Bearish
Neutral
Bullish
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
1 unique insiders with 5 transactions. Net insider value: -$14.8M ($0.00 bought, $14.8M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 17, 2026 | Yeganeh Reuven | Director | C | 530,000 | $2.00 | $1.1M |
| Mar 17, 2026 | Yeganeh Reuven | Director | SELL | 530,000 | $5.00 | $2.6M |
| Mar 17, 2026 | Yeganeh Reuven | Director | C | 1,060 | $0.00 | $0.00 |
| Mar 16, 2026 | Yeganeh Reuven | Director | C | 450,000 | $2.00 | $900.0K |
| Mar 16, 2026 | Yeganeh Reuven | Director | SELL | 450,000 | $5.00 | $2.3M |
| Mar 16, 2026 | Yeganeh Reuven | Director | C | 900 | $0.00 | $0.00 |
| Mar 16, 2026 | Yeganeh Reuven | Director | SELL | 1,300,000 | $5.00 | $6.5M |
| Mar 13, 2026 | Yeganeh Reuven | Director | SELL | 370,000 | $5.00 | $1.9M |
| Mar 13, 2026 | Yeganeh Reuven | Director | C | 370,000 | $2.00 | $740.0K |
| Mar 13, 2026 | Yeganeh Reuven | Director | C | 740 | $0.00 | $0.00 |
| Mar 12, 2026 | Yeganeh Reuven | Director | SELL | 300,000 | $5.00 | $1.5M |
| Mar 12, 2026 | Yeganeh Reuven | Director | C | 600 | $0.00 | $0.00 |
| Mar 11, 2026 | Yeganeh Reuven | Director | C | 300,000 | $2.00 | $600.0K |
5 SEC filing reports analyzed. Sentiment: 2 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 4.8/10.
NEUTRAL
8-K
2/10
BiomX Inc. appointed Roy Rousso as Chief Business Officer (and, per the consulting agreement, COO/CB
May 28, 2026
NEUTRAL
10-K/A
3/10
BiomX filed Amendment No. 1 to its 2025 10-K solely to add Part III items (directors, executive comp
Apr 30, 2026
NEUTRAL
8-K
5/10
BiomX subsidiary Zorronet secured a framework supply agreement with Israel Railways to deploy AI-pow
Apr 16, 2026
BULLISH
8-K
7/10
BiomX Inc. completed the acquisition of DFSL, a defense technology company, using a combination of c
Apr 13, 2026
BULLISH
8-K
7/10
BiomX Inc. completed the acquisition of ZorroNet, an AI-powered defense technology company, using a
Apr 10, 2026
Historical analyst distribution (last covering-analyst action Mar 2026): 75% buy across 8 analysts — 2 strong buy, 4 buy, 2 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Mar 2026. No current recommendation available.
$304.00 mean target (Mar 2026)
$304.00 Low
$304.00 High
| Metric | Value |
|---|---|
| Current Price | $0.5902 |
| Target Low | $304.00 |
| Target Mean | $304.00 |
| Target Median | $304.00 |
| Target High | $304.00 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-12-31 |
$-5.85 | $-5.85 | $-5.85 | 73.6% | +0.0% | — | $0.0B | 0.0% | 1 |
| Next FY 2027-12-31 |
$-6.01 | $-6.01 | $-6.01 | -2.7% | +53.7% | 1↑ 1↓ | $0.0B | 0.0% | 1 |
1 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Mar 9, 2026 | HC Wainwright & Co. | DOWNGRADE | Buy | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| May 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Apr 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Mar 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Feb 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Jan 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
57°
Neutral
Bearish
Neutral
Bullish
3 mentions
1 bullish
0 bearish
3 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Apr 20, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 20, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Apr 20, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
21 MAY 2026 , WHAT ARE THE BIGGEST WINNERS AND WHY
▲ 1
💬 1
⚡ 0.5
BiomX (PGHE) ... over the last week.
▲ 1
💬 1
⚡ 0.5
PHGE over the weekend ...
▲ 1
💬 0
⚡ 0.5
Jun 2, 2026
other
Another Prominent Defense Technology Leader Joins BiomX: Prof. Gabby Sarusi, Former VP and Chief Scientist at Elbit
Defense-industry veteran brings experience developing imaging, sensing, and intelligence systems for aerospace, defense, and homeland security <pre>De
Jun 1, 2026
other
Zorronet Brings Autonomous C5ISR to Hardened Sites Without Public Cloud Dependence
The company introduces an expanded on-premise and hybrid C5ISR suite that enables local AI processing, command automation, and response coordination f
May 27, 2026
other
BiomX Appoints IDF Colonel (res.) Roy Timor-Rousso as Chief Business Officer to Strengthen Defense & Security Operations
Roy brings defense leadership, digital infrastructure, and large scale commercialization experience as BiomX advances its defense and security transit
May 27, 2026
short_volume
Short Volume: PHGE — 55.5% short (1.2M / 2.2M)
Short: 1,203,425 | Exempt: 93,381 | TRF Vol: 2,168,115 | Short Ratio: 55.5% | Off-exchange volume (dark pool + OTC)
May 22, 2026
short_volume
Short Volume: PHGE — 59.0% short (4.6M / 7.7M)
Short: 4,572,101 | Exempt: 579,388 | TRF Vol: 7,743,549 | Short Ratio: 59.0% | Off-exchange volume (dark pool + OTC)
May 13, 2026
earnings_calendar
PHGE Q1 2026 Earnings Scheduled — 2026-05-13
May 6, 2026
other
BiomX’s Zorronet Puts Full AI Command-and-Control in the Palm of Your Hand
Transforms fragmented communication into real-time, AI-driven coordination, assignment, and guided response <pre>Transforms fragmented communication i
Apr 16, 2026
contract
Zorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection Systems
AI-driven command and control platform applied in real-world railway operations, supporting broader infrastructure and security use cases <pre>AI-driv
Apr 13, 2026
m_and_a
BiomX Accelerates Defense Technology Buildout with DFSL Acquisition
Acquisition expands BiomX’s defense portfolio with aligned capabilities designed to integrate across detection, analysis, and response, reinforcing it
Apr 10, 2026
m_and_a
BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications
Targets $81B command-and-control and video analytics markets by 2030, driven by real-time situational awareness in defense environments <pre>Targets $
Mar 31, 2026
m_and_a
BiomX Obtains Option to Acquire Control of Israeli Laser-Radar Counter-Drone System
The platform delivers ~99% accuracy in real-world deployments across defense and infrastructure; When closed, the transaction value is estimated at ap
Mar 30, 2026
other
BiomX Adds Former Mossad Deputy to Advisory Board
Dr. Ehud (Udi) Levi brings decades of intelligence experience as Company evaluates expansion into security, defense, and counter-UAS technologies <pre
Mar 27, 2026
critical
BiomX Inc. Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency
Discloses “Going Concern” Explanatory Paragraph in Auditor’s Report <pre>Discloses “Going Concern” Explanatory Paragraph in Auditor’s Report</pre>
Mar 26, 2026
other
BiomX Launches Security Subsidiary in Israel and Will Initially Invest Over $3 million In Its Operations
Initiative marks entry into Israel’s rapidly growing autonomous AI defense, firefighting and first response activities <pre>Initiative marks entry int